Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 6/20 | 0.48 |
| ▸ | REN | P00797 | 4/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | F2 | P00734 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | LTA4H | P09960 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | PEPD | P12955 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | HRH1 | P35367 | 1/20 | 0.46 |
| ▸ | THPO | P40225 | 1/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.46 |
| ▸ | DPP4 | P27487 | 5/20 | 0.44 |
| ▸ | DPP8 | Q6V1X1 | 4/20 | 0.44 |
| ▸ | DPP9 | Q86TI2 | 4/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2113641 | 1.00 | ACE (0.48) | ACERENKDM4EF2LMNA | |
| SCHEMBL31688030 | 0.96 | DPP7 (0.44) | ACERENKDM4EF2LMNA | |
| SCHEMBL3451623 | 0.90 | ACE (0.46) | ACERENKDM4EF2LMNA | |
| SCHEMBL1674799 | 0.90 | ACE (0.46) | ACERENKDM4EF2LMNA | |
| SCHEMBL2114955 | 0.90 | ACE (0.46) | ACERENKDM4EF2LMNA | |
| SCHEMBL2114959 | 0.90 | ACE (0.46) | ACERENKDM4EF2LMNA | |
| SCHEMBL27775712 | 0.90 | ACE (0.46) | ACERENKDM4EF2LMNA | |
| SCHEMBL30416742 | 0.86 | ACE (0.46) | ACERENKDM4EF2LMNA | |
| SCHEMBL7272757 | 0.86 | ACE (0.43) | ACERENKDM4EF2LMNA | |
| SCHEMBL11037632 | 0.86 | ACE (0.43) | ACERENKDM4EF2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119031938-A | Compounds and uses | 同宜医药（苏州）有限公司 | 2024-11-26 | — | — | CN | claimed |
| CN-119031938-A | Compounds and uses | 同宜医药（苏州）有限公司 | 2024-11-26 | — | — | CN | disclosed |
| EP-2841084-A1 | PEPTIDES AND USE THEREOF IN THE TREATMENT OF LARGE CELL LUNG CANCER | Biokine Therapeutics Ltd. (IL) | 2015-03-04 | — | — | EP | disclosed |
| WO-2013160895-A1 | PEPTIDES AND USE THEREOF IN THE TREATMENT OF LARGE CELL LUNG CANCER | BIOKINE THERAPEUTICS LTD. (IL) | 2013-10-31 | — | — | WO | disclosed |
| EP-2442822-A2 | PEPTIDE THERAPY FOR INCREASING PLATELET LEVELS | Biokine Therapeutics Ltd. (IL) | 2012-04-25 | — | — | EP | disclosed |
| WO-2010146578-A2 | PEPTIDE THERAPY FOR INCREASING PLATELET LEVELS | BIOKINE THERAPEUTICS LTD. (IL) | 2010-12-23 | — | — | WO | disclosed |
| EP-2104507-A2 | T-140 PEPTIDE ANALOGS HAVING CXCR4 SUPER-AGONIST ACTIVITY FOR CANCER THERAPY | Biokine Therapeutics LTD. (IL) | 2009-09-30 | — | — | EP | disclosed |
| EP-2094274-A2 | T-140 PEPTIDE ANALOGS HAVING CXCR4 SUPER-AGONIST ACTIVITY FOR BONE MARROW RECOVERY | Biokine Therapeutics LTD. (IL) | 2009-09-02 | — | — | EP | disclosed |
| WO-2008075369-A2 | T-140 PEPTIDE ANALOGS HAVING CXCR4 SUPER-AGONIST ACTIVITY FOR BONE MARROW RECOVERY | BIOKINE THERAPEUTICS LTD. (IL) | 2008-06-26 | — | — | WO | disclosed |
| WO-2008075371-A2 | T-140 PEPTIDE ANALOGS HAVING CXCR4 SUPER-AGONIST ACTIVITY FOR IMMUNOMODULATION | BIOKINE THERAPEUTICS LTD. (IL) | 2008-06-26 | — | — | WO | disclosed |
| WO-2008075370-A2 | T-140 PEPTIDE ANALOGS HAVING CXCR4 SUPER-AGONIST ACTIVITY FOR CANCER THERAPY | BIOKINE THERAPEUTICS LTD. (IL) | 2008-06-26 | — | — | WO | disclosed |